Abdulbaqi, I.M.; Assi, R.A.; Yaghmur, A.; Darwis, Y.; Mohtar, N.; Parumasivam, T.; Saqallah, F.G.; Wahab, H.A.
Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update. Pharmaceuticals 2021, 14, 725.
https://doi.org/10.3390/ph14080725
AMA Style
Abdulbaqi IM, Assi RA, Yaghmur A, Darwis Y, Mohtar N, Parumasivam T, Saqallah FG, Wahab HA.
Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update. Pharmaceuticals. 2021; 14(8):725.
https://doi.org/10.3390/ph14080725
Chicago/Turabian Style
Abdulbaqi, Ibrahim M., Reem Abou Assi, Anan Yaghmur, Yusrida Darwis, Noratiqah Mohtar, Thaigarajan Parumasivam, Fadi G. Saqallah, and Habibah A. Wahab.
2021. "Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update" Pharmaceuticals 14, no. 8: 725.
https://doi.org/10.3390/ph14080725
APA Style
Abdulbaqi, I. M., Assi, R. A., Yaghmur, A., Darwis, Y., Mohtar, N., Parumasivam, T., Saqallah, F. G., & Wahab, H. A.
(2021). Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update. Pharmaceuticals, 14(8), 725.
https://doi.org/10.3390/ph14080725